adverse reactions incidence

Related by string. * ADVERSE . Adverse : adverse determinations . adverse impacts . adverse effects . FDA MedWatch Adverse Event / Reactions . Reaction . REACTION . REACTIONS : Reader Reaction These . knee jerk reaction . knee jerk reactions . threatening allergic reaction / incidences . Incidence . Incidences : colorectal cancer incidence . Colorectal cancer incidence . ERBITUX incidence * *

Related by context. Frequent words. (Click for all words.) 75 laboratory abnormalities 70 treatment emergent adverse 69 leukopenia 65 events AEs 65 nasopharyngitis 63 discontinuations due 63 Adverse events 63 hypokalemia 62 febrile neutropenia 62 infusion reactions 60 confidence interval #.#-#.# 60 mucositis 59 severe renal impairment 59 valacyclovir 59 mg BID 59 events SAEs 59 hyperactivity impulsivity 59 hypomagnesemia 58 TORISEL 58 CMV infection 58 antihypertensive medications 58 GERD symptoms 58 VUR 57 thrombocytopenia 57 virologic failure 57 chronic HCV infection 57 thromboembolic events 57 hypercalcemia 57 JANUVIA 57 Keppra ® 57 AEs 57 HbA1c levels 57 Adverse reactions 57 Malignant gliomas 57 peginterferon alfa 2b 56 placebo p 56 RLS symptoms 56 neutropenia 56 lopinavir ritonavir 56 FOLFOX 56 hepatic impairment 56 ACTEMRA 56 tamsulosin 56 dose regimens 56 candidiasis 56 g trans fats 55 serum phosphorus 55 impaired renal 55 mg dose 55 Ph + ALL 55 renal impairment 55 plaque psoriasis 55 nasopharyngeal cancer 55 myalgia 55 LEXIVA 55 % CI #.#-#.# [006] 55 levetiracetam 55 & s2 = 55 mg doses 55 vaginal atrophy 55 certolizumab pegol 55 febuxostat 55 ketoconazole 55 adalimumab 55 non Hodgkin lymphomas 55 Welchol 55 REMICADE ® 55 chronic HCV 54 stable angina 54 herpes zoster 54 lamotrigine 54 mg d 54 Obstructive sleep apnea 54 vertebral fracture 54 ZOSTAVAX 54 musculoskeletal pain 54 enalapril 54 #mg dose [003] 54 invasive cervical cancer 54 54 nmol L 54 orthostatic hypotension 54 statistically significant p 53 fingolimod 53 GEMZAR 53 nondiabetic 53 dose limiting toxicities 53 atopic 53 Testicular cancer 53 confidence interval CI 53 milligrams mg 53 vasomotor symptoms 53 hypersensitivity reactions 53 hypocalcemia 53 adverse reactions 53 medullary thyroid cancer 53 REVLIMID ® 53 grams dietary fiber 53 & co1 = 53 SAEs 53 P = .#

Back to home page